1. NLRC4, ASC and Caspase-1 Are Inflammasome Components That Are Mediated by P2Y2R Activation in Breast Cancer Cells
   Hana Jin et al, 2020, IJMS CrossRef
2. ESM-1 Overexpression is Involved in Increased Tumorigenesis of Radiotherapy-Resistant Breast Cancer Cells
   Hana Jin et al, 2020, Cancers CrossRef
3. Signaling Through Purinergic Receptor P2Y2 Enhances Macrophage IL-1β Production
   Gonzalo de la Rosa et al, 2020, IJMS CrossRef
4. Interleukin-1β and Cancer
   Cédric Rébé et al, 2020, Cancers CrossRef
5. NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer
   Margherita Sonnessa et al, 2020, Front. Oncol. CrossRef
6. Extracellular ATP Mediates Cancer Cell Migration and Invasion Through Increased Expression of Cyclooxygenase 2
   Shilpa Sharma et al, 2021, Front. Pharmacol. CrossRef
7. Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling
   Hana Jin et al, 2021, Cancers CrossRef
8. Autocrine and paracrine purinergic signaling in the most lethal types of cancer
   M. Reyna-Jeldes et al, 2021, Purinergic Signalling CrossRef
9. Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients
   Concetta Saponaro et al, 2021, Front. Oncol. CrossRef